GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared the...
GMA Capital Partners Joins Responsible Investment Association Australasia
SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- GMA Capital Partners has been approved as a member of the Responsible Investment Association Australasia (RIAA), reflecting the firm's continued focus on responsible capital deployment and engagement with...
KT&G's Indonesian Factory Acquires 'ISO 45001' Certification
- Establishes overseas manufacturing system meeting global health & safety standards following Korean sites SEOUL, South Korea, Jan. 5, 2026 /PRNewswire/ -- KT&G's Indonesian Factory acquired the "ISO 45001" certification, an international...
C&R Research, the 'K-Clinical Hub', Strengthens Partnerships in Indonesia
Accelerating Indonesia Collaboration through Global Clinical Capabilities SEOUL, South Korea, Jan. 5, 2026 /PRNewswire/ -- C&R Research, founded in 1997 as Korea's first full-service Contract Research Organization (CRO), has played a pivotal...
Hyundai Motor Group Executive Chair Chung Presents 2026 Vision: Customer-Focused Transformation and AI-Driven Ecosystem Collaboration
Executive Chair Chung emphasizes customer-focused transformation and ecosystem strengthening to navigate evolving market dynamics and lead new industry standards Presents strategic priorities, including agile decision-making, ecosystem...
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
- The P hase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 in participants with diabetes. Enrollment is expected to begin in the...
CTA: Despite Tariffs and Economic Headwinds, U.S. Consumer Tech Revenue to Hit $565 Billion in 2026
LAS VEGAS, Jan. 5, 2026 /PRNewswire/ -- As tariff pressures and economic uncertainty impact the business landscape, the Consumer Technology Association (CTA)® today is releasing its U.S. Consumer Technology Industry Forecast showing the industry is...
Babies Bliss Establishes a New Standard for Fertility Wellness in Singapore with a Whole-Person, Cycle-Aware Model
Singapore-based Fertility Wellness House positions complementary care as long-term support alongside IVF and assisted fertility treatments SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Babies Bliss, a leading fertility wellness house in Singapore, is...